Clinical trial
Hybrid Effectiveness-Implementation Trial of Guided Relaxation and Acupuncture for Chronic Sickle Cell Disease Pain
NCT04906447 is registered in ClinicalTrials.gov with University of Illinois at Chicago as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Hybrid Effectiveness-Implementation Trial of Guided Relaxation and Acupuncture for Chronic Sickle Cell Disease Pain
- Lead sponsor
- University of Illinois at Chicago
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 24, 2021
- Completion date
- February 28, 2026
- Enrollment
- 379 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
sickle cell disease